UBTH Blog & News



This is to specially invite you to the 10th annual thanksgiving service of the hospital. The theme of this year’s thanksgiving service is “Bless the Lord oh my soul” Psalm 103:1 and it is scheduled as follows;

Date: 14th December, 2022
Venue: Oba Akenzua Hall, UBTH
Time: 1:00 pm prompt.

Your presence and that of your colleagues is highly coveted in this avenue of corporate worship.

UBTH is committed to the health and safety of our clients and staff. To that end, please read the following information on transmission, prevention, treatment and protocols for yellow fever outbreaks. As we work together, we will keep our communities safe.


 Yellow fever (YF) is a potentially fatal viral haemorrhagic disease. 
 The YF virus is endemic in tropical areas of Africa and Central and South America.


 The incubation period (interval from infection to onset of symptoms) is usually from 3 to 6 days.
Acute phase
 Fever, headache, muscle aches, backache, chills, nausea and vomiting
Toxic phase
 Fever, jaundice (yellowness of the eyes and skin), abdominal pain with vomiting, problems with kidney function and bleeding from the mouth, nose, eyes and/or stomach.


 Humans and monkeys are the main animals infected by the virus.
 YF is transmitted to humans through the bite of infected mosquitoes (Aedes spp).
 Aedes mosquitoes bite all day
 Infected people can transmit the infection to mosquitoes for up to five days after the onset of symptoms.
 The infection is not spread directly from person to person or from animal to person. 


 There is no specific treatment for YF; only good supportive treatment for symptoms. 
 Vaccination is the most effective way to prevent yellow fever.
Vaccination  A single dose of yellow fever vaccination provides life-long protection. (Booster dose after 10 years is not needed)
Anti-mosquito measures: 
 Remove potential mosquito breeding sites around the home– drain stagnant water, clear out drains, cover water containers, etc.
 Clear bushes around dwellings.
 Sleep under insecticidetreated bed nets.
 Screen windows and doors with nets.  
 Wear long sleeved shirt and long trousers when outside. 
 Use of insecticides, mosquito repellent.
 Take extra precautions when travelling to areas with a higher risk of mosquito-borne diseases. 
 Health-care workers should have a high index of suspicion.
 Isolate infected patients being managed in a mosquito-proof room.






Symptoms – Fever, headache, muscle aches, backache, chills, nausea and vomiting, jaundice, abdominal pain, bleeding from the mouth, nose and eyes.

Exposure  History of travel to an area where there was an outbreak or endemic for yellow fever within 6 days of becoming ill.

YF Vaccination: History of YF vaccination.


Standard case definitions for yellow fever:

Suspected case: Any person with acute onset of fever with jaundice appearing within 14 days of onset of the first symptoms.

Probable case: A suspected case AND one (1) of the following – Epidemiological link to a confirmed case or an outbreak; Positive post-mortem liver histopathology.

Confirmed case: Any suspected case with positive laboratory test for yellow fever.


 Isolate patient with suspected Yellow fever in a mosquito-proof room immediately.
 Blood sample should be taken for:
 Bedside clotting time: Use pre-labelled plain bottle (Not diagnostic but may be helpful especially for clients who present with bleeding problems).
 PCR: Use two (2) pre-labelled EDTA bottles. Draw 5mls each for adults/3mls each for children and stored/transported in cold packs
 Observe standard precautions always.
 Inform contacts of suspected case immediately.


Supportive care with specific attention to fluid and electrolyte management. 

Appropriate antibiotics if there is superimposed infection.

Avoid hepatotoxic drugs, Aspirin, NSAIDs.


 Notify the Infection Control Unit, Department of Community Health, UBTH. (08023355029)
 Notify the Infectious Disease Unit, Department of Medicine, UBTH. (08063522265)
 Notify the Infectious Disease Unit, Department of Child Health, UBTH. (08033435312)


UBTH Management Team Visits Oba of Benin

The CMD, Prof. D. E. Obaseki addressing His Royal Majesty and palace Chiefs during the visit.

The Management team of the University of Benin Teaching Hospital led by the Chief Medical Director, Professor Darlington Ewaen Obaseki paid a courtesy visit on the Oba of Benin, His Royal Majesty, Omo n’oba n’edo Uku Akpolokpolo, Oba Ewuare II in his palace.

Speaking at the occasion, Professor Obaseki said they were in the palace to inform His Majesty of his appointment as the Chief Medical Director, introduce other members of his management team as well as to seek His Royal blessings in discharging their responsibility of providing care to the people.

Welcoming the management team, Oba Ewuare II congratulated the Chief Medical Director on his appointment and urged him to do everything within his power to ensure that the incessant strikes by health care providers is brought to the barest minimum as they do not benefit anybody. He enjoined other members of the UBTH Management to give the Chief Medical Director their maximum support to enable him improve on the successes so far recorded in the hospital.

Other members of Management on the entourage were: the Chairman, Medical Advisory Committee, Prof. Casimir Omuemu; Deputy Chairman, Medical Advisory Committee, (Research, Ethics and Training), Dr. Omokhua. Adeleye; Deputy Director, Finance & Accounts, Mr. K  U. Isibor; Deputy Director/Head, Nursing Services, Mrs. E.A. Osian. Others were, the Assistant Director, Human Resources, Mr. Jimoh Kadiri, who represented the Director of Administration, Mrs. A. P. Omoregie and the Head, Public Relations and Protocols Unit of the hospital, Uwaila I.Joshua, Esq.


UBTH © 2023. All rights reserved.